Evidence map›Paper›PMID 40920767›Full record

ArticlePloS one2025

"Colorectal Cancer Care Quality in a Developing Country: Insights from a Comparison of Teaching and Non-teaching Hospitals in Iran".

Mohammad Reza Rouhollahi, Mahdi Aghili, Saeed Nemati, Mohammad Ali Mohagheghi, Farid Azmoudeh Ardalan, Habibollah Mahmoodzadeh, Mehrzad Mirzania, Mohammad Shirkhoda, Seyed Hossein Yahyazadeh, Ahad Muhammadnejad and 3 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammad Reza RouhollahiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-1380-8266
Mahdi AghiliRadiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Saeed NematiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali MohagheghiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farid Azmoudeh ArdalanCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Habibollah MahmoodzadehCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mehrzad MirzaniaCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad ShirkhodaCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Hossein YahyazadehClinical Cancer Research Center, Milad Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ahad MuhammadnejadCancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sepideh AbdiCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maedeh Zokaei NikooDepartment of Outcome Research, Cleveland Clinic, Ohio, United States of America.ORCID https://orcid.org/0000-0002-6247-8910
Kazem ZendehdelCancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-0269-4945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur study represents the first effort in the Eastern Mediterranean Region to identify disparities in the quality of colorectal cancer (CRC) care in Iran.

methodsWe established a collaborative registry program for non-metastatic CRC patients to evaluate survival rates between teaching cancer centers (TCCs) and a high-volume, non-teaching, non-cancer center (NTNC). The study included a diverse patient population and considered various factors such as cancer stage, margin involvement, adherence to guidelines for adjuvant and neoadjuvant treatments, emergency surgeries, socioeconomic status, and risk of surgery. We utilized a multivariate Cox regression model and the targeted maximum likelihood estimator (TMLE) to analyze survival disparities in colorectal cancer between TCCs and the NTNC.

resultsWe recruited 668 CRC patients, including 320 with colon cancer and 298 with rectal cancer. Patients who underwent surgery at teaching cancer centers (TCCs) displayed significantly higher quality of care and better outcomes than those treated at the non-teaching, non-cancer center (NTNC). The adjusted hazard ratios (HR) were 1.97 (95% CI 1.21-3.21) for colon cancer and 1.54 (95% CI 1.01-2.55) for rectal cancer. Additionally, we observed significant causal mortality risk ratios (RR) based on hospital type for overall colorectal cancer (RR = 1.42, 95% CI 1.12-1.81) and specifically for colon (RR = 1.48, 95% CI 1.04-2.11) and rectum cancer (RR = 1.39, 95% CI 1.01-2.02).

conclusionThe survival disparities in colon and rectal cancers between TCCs and NTNCs highlight a significant gap in CRC care in Iran. It is essential to expand this study nationally and implement the knowledge and experiences from TCCs in other hospitals to improve the quality of care and enhance patient outcomes.

Indexed as

Colorectal NeoplasmsHospitals, TeachingQuality of Health CareAdultAgedDeveloping CountriesFemaleHumansIranMaleMiddle AgedProportional Hazards ModelsRegistries

Identifiers

PMID40920767
PMCPMC12416677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.